Skip to main content
. 2024 Apr 23;38:45–54. doi: 10.1016/j.bioactmat.2024.04.005

Scheme 1.

Scheme 1

Schematic illustration of the preparation of AK123/FN NCs for combined treatment of PD via M2 microglia polarization, oxidative stress mitigation, inflammatory response suppression and α-syn aggregation inhibition.